| Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study BF Voight, GM Peloso, M Orho-Melander, R Frikke-Schmidt, M Barbalic, ... The Lancet 380 (9841), 572-580, 2012 | 2665 | 2012 |
| Pharmacogenetics: from bench to byte—an update of guidelines JJ Swen, M Nijenhuis, A de Boer, L Grandia, AH Maitland‐van der Zee, ... Clinical Pharmacology & Therapeutics 89 (5), 662-673, 2011 | 1262 | 2011 |
| A randomized trial of genotype-guided dosing of warfarin M Pirmohamed, G Burnside, N Eriksson, AL Jorgensen, CH Toh, ... New England Journal of Medicine 369 (24), 2294-2303, 2013 | 990 | 2013 |
| Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data MV Holmes, CE Dale, L Zuccolo, RJ Silverwood, Y Guo, Z Ye, ... Bmj 349, g4164, 2014 | 861 | 2014 |
| HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials DI Swerdlow, D Preiss, KB Kuchenbaecker, MV Holmes, JEL Engmann, ... The Lancet 385 (9965), 351-361, 2015 | 785 | 2015 |
| PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study AF Schmidt, DI Swerdlow, MV Holmes, RS Patel, Z Fairhurst-Hunter, ... The lancet Diabetes & endocrinology 5 (2), 97-105, 2017 | 412 | 2017 |
| Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci R Saxena, CC Elbers, Y Guo, I Peter, TR Gaunt, JL Mega, MB Lanktree, ... The American Journal of Human Genetics 90 (3), 410-425, 2012 | 326 | 2012 |
| A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon TI Verhoef, G Ragia, A de Boer, R Barallon, G Kolovou, V Kolovou, ... New England Journal of Medicine 369 (24), 2304-2312, 2013 | 269 | 2013 |
| Phenotype standardization for statin‐induced myotoxicity A Alfirevic, D Neely, J Armitage, H Chinoy, RG Cooper, R Laaksonen, ... Clinical Pharmacology & Therapeutics 96 (4), 470-476, 2014 | 254 | 2014 |
| Association of liver injury from specific drugs, or groups of drugs, with polymorphisms in HLA and other genes in a genome-wide association study P Nicoletti, GP Aithal, ES Bjornsson, RJ Andrade, A Sawle, M Arrese, ... Gastroenterology 152 (5), 1078-1089, 2017 | 241 | 2017 |
| Pharmacogenetic‐guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon TI Verhoef, WK Redekop, AK Daly, RMF Van Schie, A De Boer, ... British journal of clinical pharmacology 77 (4), 626-641, 2014 | 216 | 2014 |
| Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response K Golebski, JA Layhadi, U Sahiner, EH Steveling-Klein, MM Lenormand, ... Immunity 54 (2), 291-307. e7, 2021 | 210 | 2021 |
| Is diet partly responsible for differences in COVID‐19 death rates between and within countries? J Bousquet, JM Anto, G Iaccarino, W Czarlewski, T Haahtela, A Anto, ... Clinical and translational allergy 10 (1), 16, 2020 | 173 | 2020 |
| Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design RMF Van Schie, MIA Wadelius, F Kamali, AK Daly, VG Manolopoulos, ... Pharmacogenomics 10 (10), 1687-1695, 2009 | 170 | 2009 |
| Meta-analysis of dense genecentric association studies reveals common and uncommon variants associated with height MB Lanktree, Y Guo, M Murtaza, JT Glessner, SD Bailey, ... The American Journal of Human Genetics 88 (1), 6-18, 2011 | 166 | 2011 |
| Practical recommendations for pharmacogenomics-based prescription: 2010 ESF–UB Conference on Pharmacogenetics and Pharmacogenomics L Becquemont, A Alfirevic, U Amstutz, H Brauch, E Jacqz-Aigrain, ... Pharmacogenomics 12 (1), 113-124, 2011 | 166 | 2011 |
| Drug-induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels AK Mantel-Teeuwisse, JME Kloosterman, AHM van der Zee, OH Klungel, ... Drug safety 24, 443-456, 2001 | 165 | 2001 |
| Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19 J Bousquet, JM Anto, W Czarlewski, T Haahtela, SC Fonseca, G Iaccarino, ... Allergy 76 (3), 735-750, 2021 | 148 | 2021 |
| Childhood obesity in relation to poor asthma control and exacerbation: a meta-analysis F Ahmadizar, SJH Vijverberg, HGM Arets, A de Boer, JE Lang, M Kattan, ... European Respiratory Journal 48 (4), 1063-1073, 2016 | 145 | 2016 |
| Clinical utility of asthma biomarkers: from bench to bedside SJH Vijverberg, B Hilvering, JAM Raaijmakers, JWJ Lammers, ... Biologics: Targets and Therapy, 199-210, 2013 | 138 | 2013 |
